Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: Results from a large single-centre cohort analysis. Model is adjusted for age, ...
Data from 29 studies covering brain, nasopharyngeal, oropharyngeal, esophageal, non–small cell lung, hepatocarcinoma, cervical, pancreatic, rectal cancers, and soft tissue sarcoma were analyzed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results